Trials / Completed
CompletedNCT03281278
A Prospective Study of Application of Platelet Mapping in HBV-related Acute-on-chronic-liver Failure in China
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (actual)
- Sponsor
- Nanfang Hospital, Southern Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Ineffective hemostasis or a paradoxical prothrombotic state of Acute-on-chronic liver disease (ACLF) has been well established. Thrombelastography measures the dynamics of thrombin production and provides a global assessment of coagulation incorporating the cumulative effect of the interactions at various levels between plasma components and cellular component of coagulation. And through the platelet mapping, it can help provide a picture of patients' function of platelet. This study aims to explore the predictive role of platelet mapping in ACLF prognosis, organ failure developments and short term mortality.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | standard treatment | standard medical treatment |
Timeline
- Start date
- 2017-10-30
- Primary completion
- 2018-08-13
- Completion
- 2018-08-13
- First posted
- 2017-09-13
- Last updated
- 2019-06-06
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03281278. Inclusion in this directory is not an endorsement.